Birzeit Pharmaceuticals Company (PEX:BPC)

Palestine · Delayed Price · Currency is JOD · Price in USD

3.710

0.00 (0.00%)

At close: Jul 8, 2026

-1.07% (1Y)

Market Cap	101.93M -6.5%
Revenue (ttm)	34.87M +17.7%
Net Income	8.92M +58.2%
EPS	0.23 +58.2%
Shares Out	38.76M
PE Ratio	11.41
Forward PE	n/a
Dividend	0.04 (1.35%)
Ex-Dividend Date	May 6, 2026

Volume	26
Open	3.710
Previous Close	3.710
Day's Range	3.710 - 3.710
52-Week Range	3.550 - 4.450
Beta	-0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About PEX:BPC

Birzeit Pharmaceuticals Company operates as a pharmaceutical manufacturing company in the Palestinian Authority. The company offers OTC products for alimentary system cardiovascular system, central nervous system, musculo-skeletal system, endocrine, genito-urinary system, diabetes, obstetrics and gynecology infections, affecting nutrition and metabolism, respiratory system, ophthalmic drugs, dermatological preparations, and dietary supplements, as well as ear, nose, and oropharynx therapeutic areas. It serves the Ministry of Health, healthcare ... [Read more]

Industry Pharmaceutical Preparations

Founded 1973

Employees 372

Stock Exchange Palestine Stock Exchange

Ticker Symbol BPC

Full Company Profile

Financial Performance

In 2025, PEX:BPC's revenue was $47.96 million, an increase of 17.98% compared to the previous year's $40.65 million. Earnings were $11.95 million, an increase of 130.54%.

Financial numbers in USD Financial Statements